Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

253 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Centers for disease control and prevention expert panel meetings on prevention and treatment of anthrax in adults.
Hendricks KA, Wright ME, Shadomy SV, Bradley JS, Morrow MG, Pavia AT, Rubinstein E, Holty JE, Messonnier NE, Smith TL, Pesik N, Treadwell TA, Bower WA; Workgroup on Anthrax Clinical Guidelines. Hendricks KA, et al. Emerg Infect Dis. 2014 Feb;20(2):e130687. doi: 10.3201/eid2002.130687. Emerg Infect Dis. 2014. PMID: 24447897 Free PMC article.
Recommended Adult Immunization Schedule, United States, 2019.
Kim DK, Hunter P; Advisory Committee on Immunization Practices. Kim DK, et al. Ann Intern Med. 2019 Feb 5;170(3):182-92. doi: 10.7326/M18-3600. Ann Intern Med. 2019. PMID: 30716757 Free article. No abstract available.
Anthrax lethal toxin paralyzes neutrophil actin-based motility.
During RL, Li W, Hao B, Koenig JM, Stephens DS, Quinn CP, Southwick FS. During RL, et al. Among authors: stephens ds. J Infect Dis. 2005 Sep 1;192(5):837-45. doi: 10.1086/432516. Epub 2005 Jul 21. J Infect Dis. 2005. PMID: 16088833
Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States.
Jernigan JA, Stephens DS, Ashford DA, Omenaca C, Topiel MS, Galbraith M, Tapper M, Fisk TL, Zaki S, Popovic T, Meyer RF, Quinn CP, Harper SA, Fridkin SK, Sejvar JJ, Shepard CW, McConnell M, Guarner J, Shieh WJ, Malecki JM, Gerberding JL, Hughes JM, Perkins BA; Anthrax Bioterrorism Investigation Team. Jernigan JA, et al. Among authors: stephens ds. Emerg Infect Dis. 2001 Nov-Dec;7(6):933-44. doi: 10.3201/eid0706.010604. Emerg Infect Dis. 2001. PMID: 11747719 Free PMC article.
Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant.
Lyke KE, Atmar RL, Islas CD, Posavad CM, Szydlo D, Paul Chourdhury R, Deming ME, Eaton A, Jackson LA, Branche AR, El Sahly HM, Rostad CA, Martin JM, Johnston C, Rupp RE, Mulligan MJ, Brady RC, Frenck RW Jr, Bäcker M, Kottkamp AC, Babu TM, Rajakumar K, Edupuganti S, Dobrzynski D, Coler RN, Archer JI, Crandon S, Zemanek JA, Brown ER, Neuzil KM, Stephens DS, Post DJ, Nayak SU, Suthar MS, Roberts PC, Beigel JH, Montefiori DC; DMID 21-0012 Study Group. Lyke KE, et al. Among authors: stephens ds. Cell Rep Med. 2022 Jul 19;3(7):100679. doi: 10.1016/j.xcrm.2022.100679. Epub 2022 Jun 20. Cell Rep Med. 2022. PMID: 35798000 Free PMC article. Clinical Trial.
253 results